mortality/aging
|
• 4 weeks after initiation of tamoxifen treatment
|
cellular
|
• tamoxifen-treated mouse embryonic fibroblasts exhibit increased chromosome adhesion and mis-segregation compared with control cells
|
|
• increased caspase-3-positive cells in tamoxifen-treated mouse embryonic fibroblasts
|
|
• 8 week old tamoxifen-treated mice exhibit increased intestinal erosion and necrosis compared with wild-type mice
|
|
• reduced in intestinal crypts of tamoxifen-treated mice indicating reduced cellular renewal
|
|
• increased doubling time in tamoxifen-treated mouse embryonic fibroblasts
|
digestive/alimentary system
|
• reduced in intestinal crypts of tamoxifen-treated mice indicating reduced cellular renewal
|
|
• 8 week old tamoxifen-treated mice exhibit increased intestinal erosion and necrosis compared with wild-type mice
|
growth/size/body
|
• in tamoxifen-treated mice
|
hematopoietic system
|
• tamoxifen-treated mice exhibit normal adult hematopoiesis
|
|
• enhanced self-renewal in cells from tamoxifen-treated mice
|
neoplasm